Friday, March 24, 2023
HomePress ReleaseEIN PresswireAt a steady revenue CAGR of 12.1% | Immunotherapy Drugs Market to...

At a steady revenue CAGR of 12.1% | Immunotherapy Drugs Market to Value 365.57 Billion By 2027

Emergen Research Logo

The increasing global cancer incidence and rising preference for personalized treatment over conventional treatment are driving the immunotherapy drugs market.

Immunotherapy Drugs Market Size – USD 154.40 Billion in 2019, Market Growth – at a CAGR of 12.1%, Market Trends – Rise in incidence of lifestyle-related disorders”

— Emergen Research

VANCOUER, BC, CANADA, August 30, 2022 / — The global immunotherapy drugs market is projected to be reach USD 365.57 Billion by 2027, according to a current analysis by Emergen Research. The global market for immunotherapy drugs is anticipated to expand significantly during the forecast period, due to increasing global cancer incidence. Cancer is the world’s second-largest reason of mortality. It was liable for an estimated 9.6 million fatalities in 2018. Approximately 1 in 6 mortalities was attributed to cancer worldwide. The increasing adoption of personalized treatment over conventional treatment is likely to boost the global immunotherapy drugs market during the forecast period. Rise in the incidence of lifestyle-related disorders is expected to propel the global immunotherapy drugs market during the forecast timeline.

The Global Immunotherapy Drugs Market report assesses the historical and current data along with a thorough analysis of the market dynamics. The report also sheds light on the significant market growth driving and restraining factors that are anticipated to influence the market growth through the forecast period. The report explores the effects of the pandemic on the market and its key segments and regions. It also offers a forecast estimation of the market growth in a post-COVID-19 scenario.

Get more information on market share in different regions by downloading the sample PDF report at MINUTES @

Our Free Sample Reports Includes :

In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.

Provide chapter-wise guidance on request 2021 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.

Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Emergen Research methodology.

Key Players Operating in the Global Immunotherapy Drugs Market are:

Sanofi S.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., AstraZeneca plc, BioNTech SE, Gilead Sciences, Inc., Incyte Corporation, bluebird bio, Inc., Genmab A/S, and Bayer AG


The Research covers the following objectives:

To study and analyze the Global Immunotherapy Drugs Market by key regions/countries, product type and application, history data from forecast to 2027.

To understand the structure of Immunotherapy Drugs Market by identifying its various sub-segments.

Focuses on the key global Immunotherapy Drugs Market manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter’s five forces analysis, SWOT analysis and development plans in the next few years.

To analyze the Immunotherapy Drugs Market with respect to individual growth trends, future prospects, and their contribution to the total market.

Some Key Highlights of the Report :

In September 2020, Immunomedics, Inc. was acquired by Gilead Sciences, Inc. The deal will extend Gilead’s product portfolio; also, the acquisition represented an essential step in the plan of Gilead to build a broad and inclusive oncology pipeline.

Due to the advantages of monoclonal antibodies like adaptive and highly reproductive, the monoclonal antibodies segment is anticipated to lead the immunotherapy drugs market, expanding at a rate of 12.3% during the forecast period.

In the immunotherapy drugs market, the cancer segment is expected to hold the largest market share during the forecast period. The increasing incidence of cancer, rise in research activity in this field, and insurance availability for oncology immunotherapies are factors driving the segment.

Due to the increasing spending on immunotherapy by hospitals and rising requirement for innovative treatments, the hospitals segment is projected to lead the global immunotherapy drugs market during the forecast period.

North America is expected to lead the global market for immunotherapy drugs during the forecast period, due to the escalating incidence of cancer and autoimmune disorders, increasing demand for improved cancer therapies, increasing amount of clearance by the Food and Drug Administration, and favorable reimbursement scenario.

Browse Detailed Immunotherapy Drugs Market Research Analysis report @

Emergen Research has segmented the global immunotherapy drugs market on the basis of drug type, therapeutic area, end-user, and region.

Drug Type Outlook (Revenue, USD Billion; 2017–2027)
Checkpoint Inhibitors
Monoclonal Antibodies
Interferons Alpha and Beta

Therapeutic Area Outlook (Revenue, USD Billion; 2017–2027)
Infectious Diseases
Autoimmune & Inflammatory Diseases

End-user Outlook (Revenue, USD Billion; 2017–2027)
Research Centers

Request customization of the report @

???????? ?????????:

Geographical distribution of the includes analysis of the Immunotherapy Drugs Market leading players present in the key regions of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report offers valuable insights into the market size, share, growth rate, production and consumption rate, supply and demand ratio, import/export, revenue contribution, and strategies adopted by the prominent companies located in each region. Overall, the report offers deep insights into the current and emerging trends of the Immunotherapy Drugs Market , along with the projected growth rate over the forecast timeline.


About us :

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

????? ??? ??? ??????? ??? ??????. ?? ???? ???? ??????? ?? ??? ?????? ?? ?? ??????? ????? ??? ?????????????, ?????? ??? ?? ????, ??? ?? ???? ????? ??? ??? ?????? ?? ??? ???? ?????.

Eric Lee
Emergen Research
+91 90210 91709
Visit us on social media:

Source link


Most Popular